Showing results (2391-2400 of 2,955) with videos related to
Sort By:
Pageof 296
Cancer Investigation|January 1, 1997
Insulin-like growth factor I receptor messenger RNA in the colon is unchanged during neoplasiaM E Zenilman, W GrahamCancer Investigation|January 1, 1997
Lipid-laden macrophage infiltration of human adenocarcinoma in vivo associated with taxol and GCSF treatmentN Abramson, S Castro, J D GoldsteinCancer Investigation|January 1, 1996
GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group studyL G Hicks, S P Balcerzak, M ZalupskiCancer Investigation|January 1, 1996
Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancerW D Figg, K Ammerman, N Patronas, et al.Cancer Investigation|January 1, 1997
Time to systemic metastases in patients with posterior uveal melanomaT Sato, A Babazono, J A Shields, et al.Cancer Investigation|February 21, 2002
Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome (HNPCC)Annegret Müller, Richard FishelCancer Investigation|February 21, 2002
Randomized phase II study of irinotecan plus mitomycin C vs. oxaliplatin plus mitomycin C in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerWerner Scheithauer, Gabriela V Kornek, Stefan Brugger, et al.Cancer Investigation|January 1, 1993
Chemotherapy with high-dose cytosine arabinoside and mitoxantrone for poor-prognosis myeloid leukemiasD E Reece, M B Elmongy, M J Barnett, et al.Cancer Investigation|January 1, 1993
Guanosine potentiates the antiproliferative effect of cytosine-beta-D-arabinofuranoside in melanoma cell linesY Sidi, C Panet, A Cyjon, et al.Cancer Investigation|January 1, 1993
Nonclassical platinum antitumor agents: perspectives for design and development of new drugs complementary to cisplatinN FarrellPageof 296